SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 10,544.65 |
Enterprise Value ($M) | 9,468.55 |
Book Value ($M) | 2,589.70 |
Book Value / Share | 25.97 |
Price / Book | 4.07 |
NCAV ($M) | 595.70 |
NCAV / Share | 5.97 |
Price / NCAV | 17.70 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.11 |
Return on Assets (ROA) | 0.10 |
Return on Equity (ROE) | 0.14 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 3.28 |
Current Ratio | 3.40 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | n/a |
Assets | 3,718.70 |
Liabilities | 1,129.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | n/a |
Operating Income | n/a |
Net Income | n/a |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | n/a |
Cash from Investing | n/a |
Cash from Financing | -486.70 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Vanguard Group Inc | 10.15 | 4.32 | |
13G | State Street Corp | 4.80 | -4.99 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
383,434 | 1,112,842 | 34.46 | |
365,832 | 1,105,288 | 33.10 | |
458,700 | 1,754,501 | 26.14 | |
348,645 | 1,388,133 | 25.12 | |
395,831 | 1,384,587 | 28.59 | |
(click for more detail) |
Similar Companies | |
---|---|
MRSN – Mersana Therapeutics, Inc. | MRVI – Maravai LifeSciences Holdings, Inc. |
MYGN – Myriad Genetics, Inc. | NEOG – Neogen Corporation |
NKTX – Nkarta, Inc. |
Financial data and stock pages provided by
Fintel.io